Blockchain Coinvestors Acquisition Sponsors I LLC - Nov 9, 2021 Form 3/A - Amendment Insider Report for Blockchain Coinvestors Acquisition Corp. I (BCSA)

Role: 10%+ Owner
Signature: /s/ Lou Kerner, Chief Executive Officer
Stock symbol: BCSA
Transactions as of: Nov 9, 2021
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 3/7/2022, 03:15 PM
Date Of Original Report: Nov 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BCSA	Class A Ordinary Shares						1.32M	Nov 9, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BCSA	Class B Ordinary Shares							Nov 9, 2021	Class A Ordinary Shares	9.58M		Direct	F2, F3, F4
holding	BCSA	Warrants (right to buy)							Nov 9, 2021	Class A Ordinary Shares	661K	$11.50	Direct	F2, F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares underlie up to 1,322,300 units of the issuer that Blockchain Coinvestors Acquisition Sponsors I LLC (the "Sponsor") has irrevocably committed to purchase if the underwriters of the issuer's initial public offering exercise their over-allotment option in full (or 1,244,000 units if the underwriters do not exercise their over-allotment option in full) as described in the issuer's registration statement on Form S-1 (File No. 333-259091) (the "Registration Statement"). These shares were omitted from the Sponsor's original Form 3.
F2	Held directly by the Sponsor. The Sponsor is managed by Matthew C. Le Merle, a Managing Director and Chairman of the Board of the issuer, Lou Kerner, a Managing Director and Chief Executive Officer of the issuer, and Alison Davis, a Managing Director of the issuer. Mr. Le Merle, Mr. Kerner, and Ms. Davis have voting and investment discretion with respect to the securities of the issuer held by the Sponsor. As such, each of Mr. Le Merle, Mr. Kerner and Ms. Davis may be deemed to share beneficial ownership of the securities of the issuer held by the Sponsor. Each of Mr. Le Merle, Mr. Kerner and Ms. Davis disclaims any beneficial ownership of any securities of the issuer held by the Sponsor except to the extent of their ultimate pecuniary interest.
F3	The shares of Class B ordinary shares, par value $0.00009 per share, of the issuer will automatically convert into shares of Class A ordinary shares, par value $0.0001 per share, of the issuer upon the consummation of the issuer's initial business combination as described in the Registration Statement in the section entitled "Description of Securities-Founders Shares." The shares of Class B ordinary shares have no expiration date.
F4	These shares represent Class B ordinary shares held by the Sponsor and include up to 1,250,000 shares of Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriters of the issuer's initial public offering exercise their over-allotment option as described in the Registration Statement.
F5	The warrants will become exercisable at the later of 30 days after the consummation of the issuer's initial business combination or 12 months from the completion of the issuer's initial public offering.
F6	The warrants will expire five years after the consummation of the issuer's initial business combination or earlier upon redemption of all of the issuer's outstanding common stock or the issuer's liquidation.
F7	These warrants underlie up to 1,322,300 units of the issuer that the Sponsor has irrevocably committed to purchase if the underwriters for the issuer's initial public offering exercise their over-allotment option in full (or 1,244,000 units if the underwriters do not exercise their over-allotment option in full) and represent the right to purchase up to 661,150 shares of Class A ordinary shares (or 622,000 shares if the underwriters do not exercise their over-allotment option in full). These warrants were omitted from the Sponsor's original Form 3.